Evidence map›Paper›PMID 28214238›Full record

ArticleJournal of the American Medical Directors Association2017

High Prevalence of Low Serum Biologically Active Testosterone in Older Male Veterans.

Christine F Conover, Joshua F Yarrow, Timothy J Garrett, Fan Ye, Eoin P Quinlivan, Darryl F Cannady, Mark D Peterson, Stephen E Borst

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Medical Directors Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Christine F ConoverResearch Service, North Florida/South Georgia Veterans Health System, Gainesville, FL. Electronic address: christine.conover@va.gov.
Joshua F YarrowResearch Service, North Florida/South Georgia Veterans Health System, Gainesville, FL.
Timothy J GarrettDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL.
Fan YeNorth Florida Foundation for Research and Education, University of Florida, Gainesville, FL.
Eoin P QuinlivanDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL.
Darryl F CannadyResearch Service, North Florida/South Georgia Veterans Health System, Gainesville, FL.
Mark D PetersonDepartment of Physical Medicine and Rehabilitation, University of Michigan School of Medicine, Ann Arbor, MI.
Stephen E BorstGeriatrics Research, Education, and Clinical Center, North Florida/South Georgia Veterans Health System, Gainesville, FL; Department of Applied Physiology & Kinesiology, University of Florida, Gainesville, FL.
University of Florida · USNorth Florida/South Georgia Veterans Health System · USMichigan Medicine · US

Funding

RRD VA I01 RX000142
6 · The paper itself

Abstract

objectivesAssess the prevalence of hypogonadism in older male Veterans by comparing direct measurements of total testosterone (T) and bioavailable testosterone (BioT) versus indirect BioT values derived from existing and newly developed regression analyses.

designCohort study.

settingMalcom Randall VA Medical Center, Gainesville, FL.

participantsCommunity-dwelling male Veterans aged 60 and older (n = 203). MEASUREMENTS: Total T, BioT, albumin, sex hormone-binding globulin (SHBG), and body mass index were evaluated. Blood values were assessed via liquid chromatography-tandem mass spectrometry (LC-MS/MS) and clinical or commercially available immunoassays to compare accuracy among assessment techniques. Existing and newly developed multiple regression analyses were evaluated to assess accuracy in predicting BioT.

resultsTotal T was 13.80 ± 6.25 nmol/L (398 ± 180 ng/dL) and was low (≤10.4 nmol/L or ≤300 ng/dL) in 34% of participants. SHBG was 58 ± 35 nmol/L and elevated (≥62 nmol/L) in 36% of participants. BioT was 1.94 ± 0.97 nmol/L (56 ± 28 ng/dL), with 72% of participants below the clinical cutoff (≤2.43 nmol/L or ≤70 ng/dL). Albumin was within the normal clinical range. Total T and BioT measured via immunoassay and LC-MS/MS were moderately to highly correlated, with no differences between assessment methods. Several existing predictive equations overestimated BioT by 74% to 166% within our cohort (P < .001). A newly developed regression model that included total T, SHBG, albumin, and age more accurately predicted BioT, with values correlated (r = 0.508, P < .001) and comparable to LC-MS/MS.

conclusionIn our cohort, the prevalence of low total T was higher and low BioT was markedly higher than reported in the general age-matched population, indicating a greater incidence of hypogonadism in older male Veterans. In addition, existing empiric formulae, derived from other populations produced BioT values that were considerably greater than those directly measured, whereas our newly developed regression analysis provides improved predictive capabilities for older male Veterans.

Indexed as

VeteransAgedCohort StudiesHumansMalePrevalenceTandem Mass SpectrometryTestosteroneTestosteronebioavailable testosteronehypogonadismmultiple regressionSHBGTestosterone

Identifiers

PMID28214238
PMCPMC8349505
OpenAlexW2588434295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.